Royalty Pharma Ownership | Who Owns Royalty Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

Royalty Pharma Ownership Summary

Royalty Pharma is owned by 75.59% institutional investors, 8.85% insiders, and 15.57% retail investors. Morgan stanley is the largest institutional shareholder, holding 10.22% of RPRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.77% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Royalty Pharma	75.59%	8.85%	15.57%
Sector	Healthcare Stocks	42.54%	10.82%	46.64%
Industry	Biotech Stocks	45.21%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Morgan stanley	44.16M	10.22%	$1.56B
Fmr	27.99M	6.47%	$987.37M
Capital investors	27.21M	6.29%	$960.06M
Blackrock funding, inc. /de	26.20M	6.06%	$924.35M
Blackrock	23.02M	5.13%	$606.97M
Baillie gifford	17.37M	4.02%	$612.90B
Swedbank ab	12.20M	2.82%	$430.43M
Adage capital partners gp	11.97M	2.77%	$422.15M
Vanguard group	10.94M	2.53%	$385.84M
State street	10.27M	2.38%	$362.42M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Dorsey asset management	2.35M	7.45%	$82.92M
Cutter capital management, lp	356.89K	4.84%	$11.11M
New south capital management	2.92M	4.69%	$102.96M
Patient capital management	3.12M	4.40%	$110.00M
Caledonia (private) investments pty	7.55M	4.33%	$266.28M
Lion point capital, lp	21.40K	4.29%	$754.99K
Cooper investors pty	408.44K	3.94%	$14.41M
Pacific capital partners	100.00K	3.93%	$3.53M
Regal partners	1.44M	3.62%	$50.63B
Torray investment partners	702.88K	3.36%	$24.80M

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	11.97M	0.67%	5.97M
Capital investors	27.21M	0.15%	5.33M
Norges bank	4.88M	0.02%	4.88M
Jane street group	3.15M	0.02%	2.39M
Dorsey asset management	2.35M	7.45%	2.35M

Top Sellers

Holder	Shares	% Assets	Change
Vanguard group	10.94M	0.01%	-25.44M
Fmr	27.99M	0.05%	-12.37M
Unisphere establishment	-	-	-5.00M
Viking global investors lp	-	-	-2.60M
Jupiter asset management	-	-	-2.47M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	4.88M	0.02%	4.88M	$124.50M
Dorsey asset management	2.35M	7.45%	2.35M	$82.92M
Clark capital management group	1.75M	0.39%	1.75M	$61.80M
Marshall wace, llp	1.48M	0.05%	1.48M	$52.34M
Pacer advisors	561.59K	0.05%	561.59K	$19.81M

Sold Out

Holder	Change
Financial gravity asset management	-2.00
Harbor investment advisory	-4.00
Ameritas advisory services	-7.00
Strengthening families & communities	-8.00
New millennium group	-11.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	482	3.43%	326,746,376	-4.38%	75	1.16%	287	15.26%	130	-16.13%
Jun 30, 2025	456	-1.30%	341,289,005	7.83%	80	1.51%	248	-	148	2.07%
Mar 31, 2025	3	-99.28%	2,405,220	-99.25%	-	0.01%	1	-99.58%	2	-98.51%
Dec 31, 2024	382	-3.78%	305,326,416	-0.72%	68	1.45%	210	-2.78%	129	6.61%
Sep 30, 2024	394	3.14%	307,455,539	-2.73%	68	1.40%	214	6.47%	120	-4.76%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	12.01M	2.77%	-167.60K
Vanguard Total Stock Mkt Idx Inv	11.25M	2.60%	-258.49K
Vanguard Mid Cap Index Institutional	7.99M	1.85%	86.30K
Capital Group New Perspective Comp	7.08M	1.68%	7.08M
American Funds New Perspective A	7.08M	1.68%	7.08M
Morgan Stanley Inst Growth I	5.94M	1.38%	580.21K
Morgan Stanley Growth	5.94M	1.38%	261.46K
Morgan Stanley Growth SMA	5.94M	1.38%	261.46K
MS INVF US Advantage I	5.41M	1.25%	-
MS INVF US Growth I	4.59M	1.06%	-45.55K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 19, 2025	Urist Marshall	EVP, Research & Investments	Sell	$767.58K
Dec 17, 2025	Lloyd George W.	EVP, Investments & CLO	Sell	$3.06M
Dec 18, 2025	Lloyd George W.	EVP, Investments & CLO	Sell	$1.18M
Dec 16, 2025	Urist Marshall	EVP, Research & Investments	Sell	$766.42K
Dec 15, 2025	Coyne Terrance P.	EVP & CFO	Sell	$2.53M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	26
2025 Q3	-	1
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

RPRX Ownership FAQ

Who Owns Royalty Pharma?

Royalty Pharma shareholders are primarily institutional investors at 75.59%, followed by 8.85% insiders and 15.56% retail investors. The average institutional ownership in Royalty Pharma's industry, Biotech Stocks , is 45.21%, which Royalty Pharma exceeds.

Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (44.16M shares, 10.22%), Fmr (27.99M shares, 6.47%), and Capital investors (27.21M shares, 6.29%). Together, they hold 22.99% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

Dorsey asset management is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 7.45% of its assets in 2.35M Royalty Pharma shares, valued at 82.92M$.

Who is the top mutual fund holder of Royalty Pharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Royalty Pharma shares, with 2.77% of its total shares outstanding invested in 12.01M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools